severe nasal
Generic: oxymetazoline hydrochloride 0.05%
Labeler: alaina healthcare private limitedDrug Facts
Product Profile
Brand Name
severe nasal
Generic Name
oxymetazoline hydrochloride 0.05%
Labeler
alaina healthcare private limited
Dosage Form
SPRAY
Routes
Active Ingredients
oxymetazoline hydrochloride .05 g/100mL
Manufacturer
Identifiers & Regulatory
Product NDC
73492-715
Product ID
73492-715_45841b24-2f6e-0147-e063-6394a90aa9fa
Product Type
HUMAN OTC DRUG
Marketing Category
OTC MONOGRAPH DRUG
Application Number
M012
Listing Expiration
2026-12-31
Marketing Start
2023-09-15
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
73492715
Hyphenated Format
73492-715
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
severe nasal (source: ndc)
Generic Name
oxymetazoline hydrochloride 0.05% (source: ndc)
Application Number
M012 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- .05 g/100mL
Packaging
- 1 BOTTLE, SPRAY in 1 CARTON (73492-715-15) / 15 mL in 1 BOTTLE, SPRAY
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["NASAL"], "spl_id": "45841b24-2f6e-0147-e063-6394a90aa9fa", "openfda": {"unii": ["K89MJ0S5VY"], "rxcui": ["1000990"], "spl_set_id": ["27747a10-8d1d-41c2-80b9-45452f3b9abc"], "manufacturer_name": ["ALAINA HEALTHCARE PRIVATE LIMITED"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, SPRAY in 1 CARTON (73492-715-15) / 15 mL in 1 BOTTLE, SPRAY", "package_ndc": "73492-715-15", "marketing_start_date": "20230915"}], "brand_name": "Severe Nasal", "product_id": "73492-715_45841b24-2f6e-0147-e063-6394a90aa9fa", "dosage_form": "SPRAY", "pharm_class": ["Imidazolines [CS]", "Increased Sympathetic Activity [PE]", "Vasoconstriction [PE]", "Vasoconstrictor [EPC]"], "product_ndc": "73492-715", "generic_name": "oxymetazoline hydrochloride 0.05%", "labeler_name": "ALAINA HEALTHCARE PRIVATE LIMITED", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Severe Nasal", "active_ingredients": [{"name": "OXYMETAZOLINE HYDROCHLORIDE", "strength": ".05 g/100mL"}], "application_number": "M012", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20230915", "listing_expiration_date": "20261231"}